As of 2025-07-18, the Intrinsic Value of Medcom Tech SA (MED.MC) is 0.35 EUR. This MED.MC valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 0.69 EUR, the upside of Medcom Tech SA is -48.80%.
The range of the Intrinsic Value is (0.19) - 1.99 EUR
Based on its market price of 0.69 EUR and our intrinsic valuation, Medcom Tech SA (MED.MC) is overvalued by 48.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (0.52) - 1.09 | (0.12) | -117.3% |
| DCF (Growth 10y) | (0.19) - 1.99 | 0.35 | -48.8% |
| DCF (EBITDA 5y) | (0.17) - 0.44 | 0.06 | -91.5% |
| DCF (EBITDA 10y) | (0.08) - 0.75 | 0.23 | -66.2% |
| Fair Value | -0.57 - -0.57 | -0.57 | -181.90% |
| P/E | (1.24) - (1.46) | (1.38) | -299.4% |
| EV/EBITDA | (0.20) - 0.49 | 0.12 | -83.2% |
| EPV | 2.52 - 4.81 | 3.67 | 431.3% |
| DDM - Stable | (0.84) - (3.68) | (2.26) | -427.5% |
| DDM - Multi | (0.11) - (0.39) | (0.17) | -125.2% |
| Market Cap (mil) | 8.94 |
| Beta | 1.06 |
| Outstanding shares (mil) | 12.95 |
| Enterprise Value (mil) | 26.18 |
| Market risk premium | 7.44% |
| Cost of Equity | 10.09% |
| Cost of Debt | 12.03% |
| WACC | 10.88% |